MP-110

N/A

Report date: 2022/12/17 15:14:23
NME

Base Information

Drug NameMP-110
Drug Alias NameMP-110
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAdrenocortical Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMarathon Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAdrenocortical Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A